Abstract
While the major pathogenic theory of personality disorders held by American psychiatrists is psychoanalytic (Abraham, 1949; Reich, 1949; Knight, 1953; Kernberg, 1975), the biological approach to personality disorders has an equally lengthy history. The modern era began with Kraepelin (1921), who observed affective temperaments in the premorbid history of many manic depressives and their non-ill biological relatives. Later investigators, such as Kretschmer (1936) and Schneider (1959) described constitutional factors thought to underlie both normal and deviant personality types. The major thrust of these studies was the notion that diluted versions of major schizophrenic, affective, and organic disorders could express themselves as chronic, maladaptive patterns of experiencing and functioning in the world; that is, personality disorders. With the modern tools of psychopharmacology, psychobiology, family studies, and clinical studies, these theories can be better tested.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abraham K., 1949, Selected Papers on Psychoananlysis ( 1921–1925 ), London, Hogarth Press.
Akiskal H.S., 1981, Subaffective disorders: Dysthymic, cyclothymic and bipolar II disorders in the “borderline” realm. Psychiatr. Clin. North Am. 4: 26–46.
Akiskal H.S., 1979, Khani M.K., Scott-Straus A: Cyclothymic temperamental disorders. Psychiatr. Clin. North Am. 2: 527–554.
Andrulonis P.A., Donnelly J., Glueck B.C. et al: 1980, Preliminary data on ethosuximide and the episodic dyscontrol syndrome. Am. J. Psychiatry 137: 1455–1456.
Aono T., Kaneko M., Numata Y., et al: 1981, Effects of amoxapine, a new antidepressant, on psuedoneurotic schizophrenia. Folia Psychiatr.Neurol. Japan, 35: 115–121.
Bach-Y-Rita G., Lion J.R., Climent C.E., et al: 1971, Episodic dyscontrol: A study of 130 violent patients. Am.J.Psychiatry 127: 1473–1478.
Barnes R.J: 1977, Mesoridazine (Serenitil) in personality disorders–a controlled trial in adolescent patients. Diseases of the Nervous System 38: 258–264.
Baxter L., Edell W., Gerner R., et al: 1984, Dexamethasone suppression test and Axis I diagnosis of in-patients with DSM-III borderline personality disorder. J. Clin. Psychiatry 45: 150–153.
Brinkley J.R., Beitman B.D., Friedel R.O.: 1979, Low-dose neuroleptic regimensin the treatment of borderline patients.Arch Gen Psychiatry 36: 319–326.
Brown G.L. and Goodwin F.K.: 1986, Human aggression: A biological perspective in Unmasking The Psychopath: Antisocial Personality and Related Syndromes. Edited by Reid W.M., Dorr D., Waller JI. et al. W.W. Norton, N.Y.
Carroll B.J., Greden J.F., Feinberg M., et al: 1981, Neuroendocrine evaluation of depression in borderline patients. Psychiatr. Clin. North Am. 4: 89–98.
Chodoff P.: 1974, Diagnosis of hysteria - an overview. Am. J. Psychiatry 131:1073–1078.
Elliot F.A.: 1977, Propranolol for the control of belligerent behavior following acute brain damage. Ann. Neurol 1: 489–491.
Faltus F.J.: 1984, The positive effect of alprazolam in the treatment of three patients with borderline personality disorder Am. J. Psychiatry 141: 802–803.
Feighner J.P., Herbstein J., Damlouji N.:1985, Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression. J.Clin.Psychiatry 46: 206–209
Garbutt J.C., Loosen P.T., Tipermas A., et al: 1983, The TRH test in patients with borderline personality disorder. Psychiatry Res. 9: 107–113.
Gardner D.L., Cowdry R.W.: 1985, Alprazolam–induced dyscontrol in borderline personality disorder. Am. J Psychiatry 142: 98–100.
Goldberg S.C., Schulz S.C., Schulz P.M. et al: 1986, Borderline and schizotypal personality disorders treated with low dose thothixene vs. placebo. Arch. Gen. Psychiatry, 43: 680–686.
Gunderson J.: 1984, Borderline Personality Disorder. Washington DC, American Psychiatric Press, Inc.
Hedberg D.L., Houck J.H., Glueck B.C.: 1971, Tranylcypromine–trifluoerazine combination in the treatment of schizophrenia. Am. J. Psychiatry 127: 1141–1146.
Hymowitz P., Frances A.J., Hoyt R., et al: 1984, Neuroleptic Treatment of Schizotypal Personalities. Presented at the 137th Annual Meeting of the American Psychiatric Association, Los Angeles.
Kernberg O.F.: 1975, Borderline Conditions and Pathological Narcissim. New York, Jason Aronson Inc.
Kety S.S., Rosenthal D., Wender P.H., et al: 1968, The types and prevalence of mental illness in the biological and adoptive familes of adoptive schizophrenics, in The Transmission of Schizophrenia, ed. Rosenthal D., Kety S.S., Oxford Pergamon Press.
Klein D.F.:1964, Delineation of two drug-responsive anxiety syndromes. Psychopharmacologia 5:397–408.
Klein D.F.: 1967, Importance of psychiatric diagnosis in the prediction of clinical drug effects. Arch. Gen. Psychiatry 16: 118–126.
Klein D.F.: 1975, Psychopharmacology and the borderline patient, in Borderline States in Psychiatry. Edited by Mack JE, New Yor, Grune & Stratton
Knight R.P.: 1953, Borderline states. Bull. Menningner Clin. 17: 1–11.
Kraepelin E.: 1921, Manic Depressive Insanity and Paranoia. Edinburgh, E & S Livingston.
Kretschmer E.: 1936, Physique and Character, 2nd edition. London, Routledge.
Leone N.F.: 1982, Response of borderline patients to loxapine and chlorpromazine. J. Clin. Psychiatry 43: 148–150.
Liebowitz J.H., Rudy V., Gershon E.S., et al: 1976, A pharmacogenetic case report: Lithium -responsiveness postpsychotic antisocial behavior. Compr.Psychiatry 17: 655–660.
Liebowitz M.R.: 1979, Is borderline a distinct entity? Schizophr. Bull. 5: 23–38.
Liebowitz M.R., Klein D.F.: 1979, Hysteroid dysphoria. Psychiatr. Clin. North Am. 2: 555–575.
Liebowitz M.R, Klein D.F.: 1981, Interrelationship of hysteroid dysphoria and borderline personality disorder. Psychiatr. Clin.North Am. 4: 67–87.
Liebowitz M.R., Quitkin F.M., Stewart J.W., et al: 1984, Phenelzine vs. imipramine in atypical depression:A preliminary report.Arch. Gen. Psychiatry 41: 669–677.
Liebowitz M.R., Gorman J.M., Fyer A.J., et al: Social phobia: 1985, Review of a neglected anxiety disorder. Arch. Gen. Psychiatry 42: 729–736.
Liebowitz M.R., Fyer A.J., Gorman J.M., et al: 1986, Phenelzine in social phobia. J. Clinic. Psychopharmacol. 6: 93–98.
Liebowitz M.R., et al: Obsessive compulsive disorder: Paradigmatic shift and an improved prognosis (submitted for publication)
McNamara E., Reynolds C.F., Soloff P.H., et al: 1984, EEG sleep evaluation of depression in borderline patients. Am. J. Psychiatry 141: 182–186.
Millon T.: 1969, Modern Psychopathology: A Biosocial Approach to Maladaptive Learning and Functioning. Philadelphia, WB Saunders.
Nies A., Howard D., Robinson D.S.: 1982, Antianxiety effects of MAO inhibitors, in The Biology of Anxiety, ed. Mathew RJ. New York, Brunner/Mazel.
Quitkin F., Rifkin A., Klein D.F.: 1976, Neurologic soft signs in schizophrenia and character disorders: Organicity in schizophrenia with premorbid asociality and emotionally unstable character disorders. Arch. Gen. Psychiatry 33: 845–853.
Ratey J.J., Morrill R., Oxenkrug F:. 1983, Use of propranolol for provoked and unprovoked episodes of rage, Am. J.Psychiatry 140: 1356–1357.
Reich W.:1949, Character Analysis, New York, Noonday Press.
Reyntjens A.M.: 1972, A series of multicentric pilot trials with pimozide in psychiatric practice, I: Pimozide in the treatment of personality disorders. Acta. Psychiatr. Belg. 72: 653–661.
Rifkin A., Quitkin F., Carrillo C., et al: 1972, Lithium carbonate in emotionally unstable character disorder. Arch. Gen.Psychiatry 27: 519–523.
Rosenbaum J.F.,Woods S.W., Groves J.E., et al: 1984, Emergence of hostility during alprazolam treatment. Am. J. Psychiatry 141: 792–793.
Rosenthal D., Wender P.H. Kety S.S., et al: 1968, Schizophrenics’ offspring reared in adoptive homes, in The Transmission of Schizophrenia, ed. Rosenthal D, Kety S, Oxford, Pergamon Press.
Schatzberg A.F., Cole J.O.: 1981, Benzodiazepines in the treatment of depressive, borderline personality, and schizophrenic disorders. Br. J. Clin. Pharmacol. 11: 175–225.
Schneider K.: 1959, Clinical Psychopathology. New York, Grune & Stratton. Serban G.: 1984, Borderline and schizotypal personality disorders: Criteria for diagnosis and treatment. Am. J.Psychiatry 141: 1455–1458.
Sheard M.H., Marini J.L., Bridges D.I., et al: 1976, The effect of lithium on impulsive aggressive behavior in man. Am. J. Psychiatry 133: 1409–1413.
Sheehan D.V., Coleman J.H., Greenblatt D.J., et al: 1984, Some biochemical correlates of panic attacks with agoraphobia and their response to a new treatment. Clin.Psychopharmacol. 4: 66–75.
Soloff P.H., George A., Nathan R.S,. et al:1986a, Progress in pharmacotherapy of borderline disorders. Arch. Gen. Psychiatry 43: 691–697.
Soloff P.H., George A., Nathan R.S,. et al: 1986b, Paradoxical effect of amitriptyline on borderline patients. Am. J. Psychiatry 143: 1603–1605.
Stringer AY, Joseph NC: 1983, Methylphenidate in the treatment of aggression in two patients with antisocial personality disorder. Am. J. Psychiatry 140: 1365–1366.
Stone M.H.: 1979, Contemporary shift of the borderline concept from a subschizophrenic disorder to a subaffectve disorder.Psychiatr. Clin. North Am. 2: 577–594.
Thoren J.P., Asberg M., Cronholm B., et al: 1973, Clomipramine treatment of obsessive -compulsive disorder. Arch. Gen. Psychiatry 37: 311–317.
Tupin J.P. Smith D.B., Clanon T.I., et al: 1973, The long-term use of lithium in aggressive prisoners. Compr. Psychiatry 14: 311–317.
Turnquist K., Frances R., Rosenfeld W., et al: 1983, Pemoline in attention deficit disorder and alcoholism: A case study. Am. J. Psychiatry 140: 622–624.
Wender P.H., Reimherr F.W., Wood D.R.: 1981, Attention deficit disorder (minimal brain dysfunction) in adults. Arch. Gen. Psychiatry 38: 449–456.
Wood D..R., Reimherr F.W., Wender P.H., et al:1976, Diagnosis and treatment of minimal brain dysfunction in adults. Arch. Gen. Psychiatry 33: 1453–1460.
Yerevanian B.I., Akiskal H.S.: 1979, “Neurotic,” characterological, and dysthymic depressions. Psychiatr. Clin. North Am. 2:595–617.
Yudofsky S., Williams D., Gorman J.M.: 1981, Propranolol in treatment of rage and violent behavior in patients with chronic brain syndrome. Am.J. Psychiatry 138: 218–220.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer Science+Business Media New York
About this chapter
Cite this chapter
Liebowitz, M.R. (1988). Pharmacotherapy of Personality Disorders. In: Clynes, M., Panksepp, J. (eds) Emotions and Psychopathology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1987-1_4
Download citation
DOI: https://doi.org/10.1007/978-1-4757-1987-1_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-1989-5
Online ISBN: 978-1-4757-1987-1
eBook Packages: Springer Book Archive